搜尋結果
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 4 日前The FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, ...
California Cuts Cost of Overdose-Reversal Drug by 40% in Generic Deal
Bloomberg· 5 日前... efforts to combat surging opioid-related deaths by teaming with a maker of generic< ... ...
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Reuters· 2 日前, opens new tab raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly ...
Buy this 'dirt-cheap,' top-rated dividend stock with a 4% yield, Morningstar says
CNBC· 5 日前There's one dividend stock that Morningstar says is "deeply undervalued" right ...
White House Aims to Reclassify Marijuana as Less Dangerous Drug - What’s News - WSJ Podcasts
The Wall Street Journal· 3 日前Annmarie Fertoli: The Biden administration wants to reclassify marijuana as a less dangerous ...
Sandoz reaches agreement with Amgen over patent dispute
Reuters· 4 日前Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S ...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 4 日前Pfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired ...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Reuters· 16 小時前, opens new tab said on Friday it had reached a deal valued at more than $270 million to ...
The Blogger Turned UHNW Travel Agent
Forbes· 1 日前Today’s top private travel agents spend months on the road, road-testing trips or meeting ...
Bausch Health investors are left in a holding pattern as 2 major overhangs remain unresolved
CNBC· 2 日前Bausch Health Companies on Tuesday morning reported first-quarter top- and bottom-line misses — ...